| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
55,637 |
43,207 |
$3.87M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
28,984 |
19,096 |
$716K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
34,524 |
20,590 |
$697K |
| 90837 |
Psychotherapy, 53 minutes with patient |
5,458 |
1,988 |
$197K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
9,466 |
5,636 |
$123K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
2,709 |
1,954 |
$88K |
| 98940 |
|
5,093 |
2,126 |
$55K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
4,819 |
3,697 |
$43K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
481 |
394 |
$42K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,619 |
3,270 |
$30K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
3,567 |
2,485 |
$25K |
| 90834 |
Psychotherapy, 45 minutes with patient |
666 |
350 |
$23K |
| J1071 |
Injection, testosterone cypionate, 1 mg |
2,685 |
1,212 |
$15K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
190 |
122 |
$15K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,412 |
1,062 |
$14K |
| 96127 |
|
4,261 |
2,329 |
$13K |
| 99215 |
Prolong outpt/office vis |
384 |
357 |
$13K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
274 |
230 |
$13K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
641 |
326 |
$11K |
| 90674 |
|
495 |
351 |
$10K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
182 |
169 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
226 |
145 |
$8K |
| 82962 |
|
4,097 |
2,464 |
$5K |
| 99385 |
|
72 |
40 |
$5K |
| 87428 |
|
116 |
80 |
$5K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
108 |
96 |
$4K |
| 80305 |
|
655 |
414 |
$3K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
173 |
105 |
$3K |
| 97012 |
|
417 |
255 |
$3K |
| 81002 |
|
2,850 |
2,027 |
$3K |
| 83986 |
|
983 |
754 |
$2K |
| 82271 |
|
1,074 |
840 |
$2K |
| 90791 |
Psychiatric diagnostic evaluation |
50 |
26 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
438 |
283 |
$2K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
182 |
106 |
$2K |
| 20610 |
|
36 |
24 |
$1K |
| 93000 |
|
89 |
48 |
$1K |
| 90832 |
Psychotherapy, 30 minutes with patient |
60 |
25 |
$1K |
| 90700 |
|
158 |
115 |
$933.75 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
52 |
40 |
$587.73 |
| 97014 |
|
86 |
60 |
$529.34 |
| 90658 |
|
21 |
21 |
$431.45 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
116 |
85 |
$365.48 |
| 90670 |
|
69 |
46 |
$348.75 |
| 90713 |
|
62 |
38 |
$292.50 |
| 88150 |
|
51 |
50 |
$287.50 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
122 |
87 |
$232.78 |
| 90648 |
|
49 |
30 |
$225.00 |
| 90734 |
|
25 |
13 |
$135.00 |
| 1159F |
|
55 |
53 |
$57.51 |
| 3044F |
|
396 |
315 |
$37.01 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
530 |
493 |
$36.00 |
| 1160F |
|
42 |
40 |
$22.99 |
| 94760 |
|
393 |
382 |
$19.57 |
| 3074F |
|
10,492 |
7,605 |
$10.21 |
| 3078F |
|
9,269 |
6,868 |
$10.21 |
| 36415 |
Collection of venous blood by venipuncture |
420 |
405 |
$6.72 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
50 |
40 |
$6.00 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
20 |
20 |
$0.20 |
| 3080F |
|
853 |
709 |
$0.00 |
| 4050F |
|
199 |
182 |
$0.00 |
| 1000F |
|
4,062 |
3,488 |
$0.00 |
| 97802 |
|
13 |
12 |
$0.00 |
| Z71.8 |
|
47 |
47 |
$0.00 |
| 3075F |
|
2,453 |
1,893 |
$0.00 |
| 3079F |
|
4,917 |
3,669 |
$0.00 |
| 2000F |
|
1,607 |
1,380 |
$0.00 |
| 3351F |
|
782 |
593 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
31 |
27 |
$0.00 |
| 90899 |
|
13 |
13 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
113 |
95 |
$0.00 |
| Z71.3 |
|
48 |
48 |
$0.00 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
12 |
12 |
$0.00 |
| 4019F |
|
214 |
194 |
$0.00 |
| 90461 |
|
333 |
311 |
$0.00 |
| 3077F |
|
2,052 |
1,607 |
$0.00 |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
83 |
82 |
$0.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
55 |
54 |
$0.00 |
| A4617 |
Mouth piece |
49 |
40 |
$0.00 |
| 3046F |
|
17 |
13 |
$0.00 |